$59.99
0.72[1.21%]
At close: Apr 17
$59.99
0[0.00%]
PreMarket: 4:05PM EDT
Keros Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Keros Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/02/2024 | PM | KROS | Q1 | -$1.26 | -$1.34 | — | — | $0.00 | — | — | — | Get Alert |
02/28/2024 | PM | KROS | Q4 | -$1.09 | -$1.37 | -$1.34 | 2.19% | $0.00 | — | $143.00K | — | Get Alert |
11/06/2023 | AM | KROS | Q3 | -$0.92 | -$1.35 | -$1.33 | 1.48% | $0.00 | — | $8.00K | — | Get Alert |
08/07/2023 | AM | KROS | Q2 | -$1.13 | -$1.34 | -$1.27 | 5.22% | $0.00 | $220.00K | $0.00 | -100.00% | Get Alert |
05/04/2023 | PM | KROS | Q1 | -$1.01 | -$1.12 | -$1.26 | -12.50% | $0.00 | $220.00K | $0.00 | -100.00% | Get Alert |
03/03/2023 | PM | KROS | Q4 | -$0.30 | -$1.10 | -$1.09 | 0.91% | $20.00M | $860.00K | $0.00 | -100.00% | Get Alert |
11/03/2022 | AM | KROS | Q3 | -$0.87 | -$1.23 | -$0.92 | 25.20% | $0.00 | — | $0.00 | — | Get Alert |
08/04/2022 | PM | KROS | Q2 | -$0.67 | -$1.06 | -$1.13 | -6.60% | $100.00K | — | $0.00 | — | Get Alert |
05/05/2022 | PM | KROS | Q1 | -$0.68 | -$0.86 | -$1.01 | -17.44% | $0.00 | — | $0.00 | — | Get Alert |
03/09/2022 | PM | KROS | Q4 | -$0.49 | -$0.94 | -$0.30 | 68.09% | $0.00 | — | $20.00M | — | Get Alert |
11/04/2021 | PM | KROS | Q3 | -$0.60 | — | -$0.87 | — | $0.00 | — | $0.00 | — | Get Alert |
08/05/2021 | PM | KROS | Q2 | -$0.62 | -$0.65 | -$0.67 | -3.08% | $0.00 | — | $100.00K | — | Get Alert |
05/06/2021 | PM | KROS | Q1 | -$5.11 | -$0.58 | -$0.68 | -17.24% | $0.00 | — | $0.00 | — | Get Alert |
03/25/2021 | AM | KROS | Q4 | -$1.32 | — | -$0.49 | — | — | — | $0.00 | — | Get Alert |
11/10/2020 | PM | KROS | Q3 | -$1.71 | — | -$0.60 | — | — | — | $0.00 | — | Get Alert |
08/13/2020 | AM | KROS | Q2 | -$1.44 | — | -$0.62 | — | — | — | $0.00 | — | Get Alert |
05/22/2020 | AM | KROS | Q1 | — | — | -$5.11 | — | — | — | $0.00 | — | Get Alert |
Keros Therapeutics (KROS) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
The Actual EPS was $-1.34, which beat the estimate of $-1.37.
The Actual Revenue was $143K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.